BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17763827)

  • 1. Sumoylation regulates diverse biological processes.
    Zhao J
    Cell Mol Life Sci; 2007 Dec; 64(23):3017-33. PubMed ID: 17763827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism and function of DNA replication-independent DNA-protein crosslink repair via the SUMO-RNF4 pathway.
    Liu JCY; Kühbacher U; Larsen NB; Borgermann N; Garvanska DH; Hendriks IA; Ackermann L; Haahr P; Gallina I; Guérillon C; Branigan E; Hay RT; Azuma Y; Nielsen ML; Duxin JP; Mailand N
    EMBO J; 2021 Sep; 40(18):e107413. PubMed ID: 34346517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts.
    Celen AB; Sahin U
    FEBS J; 2020 Aug; 287(15):3110-3140. PubMed ID: 32255256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumoylation and Its Contribution to Cancer.
    Lee JS; Choi HJ; Baek SH
    Adv Exp Med Biol; 2017; 963():283-298. PubMed ID: 28197919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of transcription factors by sumoylation.
    Rosonina E; Akhter A; Dou Y; Babu J; Sri Theivakadadcham VS
    Transcription; 2017 Aug; 8(4):220-231. PubMed ID: 28379052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functions of SUMO in the Maintenance of Genome Stability.
    Zilio N; Eifler-Olivi K; Ulrich HD
    Adv Exp Med Biol; 2017; 963():51-87. PubMed ID: 28197906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting SUMOylation cascade for diabetes management.
    Sireesh D; Bhakkiyalakshmi E; Ramkumar KM; Rathinakumar S; Jennifer PS; Rajaguru P; Paulmurugan R
    Curr Drug Targets; 2014; 15(12):1094-106. PubMed ID: 25230117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation code in cancer development and metastasis.
    Kim KI; Baek SH
    Mol Cells; 2006 Dec; 22(3):247-53. PubMed ID: 17202851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Molecular Interface Between the SUMO and Ubiquitin Systems.
    Staudinger JL
    Adv Exp Med Biol; 2017; 963():99-110. PubMed ID: 28197908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The post-translational modification, SUMOylation, and cancer (Review).
    Han ZJ; Feng YH; Gu BH; Li YM; Chen H
    Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation.
    Chen S; Dong D; Xin W; Zhou H
    Curr Issues Mol Biol; 2020; 35():17-34. PubMed ID: 31422931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances on SUMO substrates in Arabidopsis].
    Guo MX; Fu YF
    Yi Chuan; 2013 Jun; 35(6):727-34. PubMed ID: 23774017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
    Hua D; Wu X
    Eur J Med Chem; 2022 Apr; 233():114227. PubMed ID: 35247754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and Analysis of SUMOylation Substrates In Vitro and In Vivo.
    Cedeño C; La Monaca E; Esposito M; Gutierrez GJ
    Methods Mol Biol; 2016; 1449():267-78. PubMed ID: 27613042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SUMO system in Caenorhabditis elegans development.
    Broday L
    Int J Dev Biol; 2017; 61(3-4-5):159-164. PubMed ID: 28621413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
    Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
    J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
    Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
    Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO proteases as potential targets for cancer therapy.
    Bialik P; Woźniak K
    Postepy Hig Med Dosw (Online); 2017 Dec; 71(0):997-1004. PubMed ID: 29225200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO and Nucleocytoplasmic Transport.
    Ptak C; Wozniak RW
    Adv Exp Med Biol; 2017; 963():111-126. PubMed ID: 28197909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of post-translational modification in breast cancer treatment.
    Heo KS
    BMB Rep; 2019 Feb; 52(2):113-118. PubMed ID: 30638182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.